All Outputs (3)

Effects of dietary polyphenols on vascular endothelium and cardiovascular health (2017)
Thesis
Ehtesham, E. (2017). Effects of dietary polyphenols on vascular endothelium and cardiovascular health. (Thesis). Hull York Medical School, the University of Hull and the University of York. Retrieved from https://hull-repository.worktribe.com/output/4219556

Introduction: Polyphenols have been suggested as being able to modulate the risk of cardiovascular disease. However, the molecular mechanisms underlying these effects are unclear and the literature lacks consistency and reproducibility, with in vitro... Read More about Effects of dietary polyphenols on vascular endothelium and cardiovascular health.

GLP-1R, a novel receptor in platelets; and the use of liraglutide in the treatment of obesity in women with PCOS (2013)
Thesis
Kahal, H. (2013). GLP-1R, a novel receptor in platelets; and the use of liraglutide in the treatment of obesity in women with PCOS. (Thesis). Hull York Medical School, the University of Hull and the University of York. Retrieved from https://hull-repository.worktribe.com/output/4215983

Studies investigating atherothrombotic risk in women with polycystic ovary syndrome (PCOS), in particular platelet function and carotid intima-media wall thickness (cIMT), have been confounded by not adequately accounting for obesity. Liraglutide is... Read More about GLP-1R, a novel receptor in platelets; and the use of liraglutide in the treatment of obesity in women with PCOS.

Cardiovascular risk reduction in insulin resistant states (2009)
Thesis
Sathyapalan, T. (2009). Cardiovascular risk reduction in insulin resistant states. (Thesis). University of Hull. Retrieved from https://hull-repository.worktribe.com/output/4212907

Introduction: Insulin resistance is the hall mark of a number of pathological conditions and is thought to play a major role in the cardiovascular risk associated with them. This thesis critically evaluates two insulin resistant conditions - polycyst... Read More about Cardiovascular risk reduction in insulin resistant states.